Skip to main content

Goldman gave clients a list of stocks that may surge if a coronavirus vaccine is approved

With several Covid-19 vaccines in Phase 3 trials, Goldman Sachs is preparing its clients for a rebound in certain stocks.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.